4 Firms Guide Clinical Stage Pharma Cos. In $221M IPOs
Clinical stage rare-disease biopharmaceutical companies Vectiv and Reneo began trading on the Nasdaq Friday after raising a collective $221 million in initial public offerings guided by four firms, including Cooley and Latham...To view the full article, register now.
Already a subscriber? Click here to view full article